Prognostic and predictive factors in patients treated with ramucirumab (RAM) with advanced hepatocellular carcinoma (aHCC) and elevated alpha-fetoprotein (AFP): Results from two phase III trials.
JOURNAL OF CLINICAL ONCOLOGY. Bd. 39. H. 15. 2021
Erscheinungsjahr: 2021
Publikationstyp: Zeitschriftenaufsatz
| Geprüft | Bibliothek |
Autoren
Llovet, Josep M. (Autor)
Singal, Amit G. (Autor)
Villanueva, Augusto (Autor)
Finn, Richard S. (Autor)
Kudo, Masatoshi (Autor)
Galle, Peter R. (Autor)
Wang, Chunxiao (Autor)
Widau, Ryan C. (Autor)
Gugel, Elena Gonzalez (Autor)
Zhu, Andrew X. (Autor)
Klassifikation
DDC Sachgruppe:
Medizin
